Search - tctmd.com

Displaying 61 - 80 of 807

Sort: Relevancy | Date

News Conference News AHA 2018

REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides

Todd Neale

November 10, 2018

News Conference News AHA 2018

VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer

Shelley Wood

November 10, 2018

News Conference News VIVA 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

L.A. McKeown

November 09, 2018

Presentation VIVA 2018

LUTONIX BTK Trial

Presenter: Jihad Mustapha

November 09, 2018

Presentation VIVA 2018

TOBA II 12-Month Data

Presenter: William Gray

November 09, 2018

Presentation VIVA 2018

1-Year Outcomes for Eluvia in Long Lesions

Presenter: William A. Gray

November 09, 2018

News Daily News

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

Michael O'Riordan

November 09, 2018

Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome

News Conference News VIVA 2018

VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease

L.A. McKeown

November 08, 2018

News Industry News

4TECH Inc. Reports First U.S. Clinical Implantations of Its TriCinch™ Coil Tricuspid Valve Repair System

November 07, 2018

News Opinion Fellow Talk

Cath Lab Hazards: Combat Them With Knowledge

Ankur Gupta, MD, PhD

November 07, 2018

News Daily News

Race May Be a Proxy for Many Disparities in CVD Treatment, Outcomes

Yael L. Maxwell

November 07, 2018

News Industry News

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

November 07, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Industry News

CardioMech Appoints Richard Nehm as President and CEO, and Mark Novotny as Chairman

November 06, 2018

News Conference News VIVA 2018

IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions

L.A. McKeown

November 06, 2018

News Daily News

Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows

Michael O'Riordan

November 06, 2018

News Daily News

High-Sensitivity Troponin Assays May Help Cut Down on Unnecessary Stress Tests, Study Suggests

Todd Neale

November 05, 2018

News Conference News AHA 2018

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Shelley Wood

November 05, 2018

News Daily News

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

Yael L. Maxwell

November 05, 2018

News Daily News

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

Shelley Wood

November 02, 2018

Advertisement

REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides

VITAL: No Benefits to Vitamin D and Omega-3s in Reducing Major CV Events, Cancer

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

LUTONIX BTK Trial

TOBA II 12-Month Data

1-Year Outcomes for Eluvia in Long Lesions

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease

4TECH Inc. Reports First U.S. Clinical Implantations of Its TriCinch™ Coil Tricuspid Valve Repair System

Cath Lab Hazards: Combat Them With Knowledge

Race May Be a Proxy for Many Disparities in CVD Treatment, Outcomes

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

CardioMech Appoints Richard Nehm as President and CEO, and Mark Novotny as Chairman

IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions

Statins Provide No Clinical Benefit When Coronary Calcium Is Zero, Study Shows

High-Sensitivity Troponin Assays May Help Cut Down on Unnecessary Stress Tests, Study Suggests

AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City

Debate Over BMS vs DES in High-Bleeding-Risk Scenarios Gets Fresh Fuel in Meta-analysis

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content